11/04/2022 - Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

10/23/2008 - Opexa Therapeutics Reports Third Quarter 2008 Financial Results

10/23/2008 - Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability ...

10/20/2008 - Opexa to Host Third Quarter Financial Results and Corporate Update Conference Call on October 23

09/19/2008 - Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of ...

09/11/2021 - Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on ...

09/03/2022 - Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program

08/14/2008 - Opexa Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights

08/13/2008 - Opexa Therapeutics Completes $3 Million Financing

07/22/2008 - Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis

07/08/2022 - Opexa's Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board

06/17/2008 - Opexa Therapeutics Appoints Neil K. Warma President and CEO

06/16/2008 - Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for ...

06/12/2021 - Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin(R) ...

05/22/2008 - Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the International Society of Cell ...

05/14/2008 - Opexa Therapeutics Schedules First Quarter Results Conference Call; May 21, 2022 at 4:00 p.m. EST

05/13/2008 - Opexa Therapeutics Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) ...

04/15/2008 - Opexa Therapeutics Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th ...

03/26/2008 - Opexa Therapeutics' Form 10-K Report Audit Includes ''Going Concern'' Qualification

03/24/2008 - Opexa Therapeutics to Present at the Cambria Capital Investor Meeting

03/21/2008 - Opexa Therapeutics Announces Retirement of CEO David McWilliams

03/18/2008 - Opexa Therapeutics Reports Year End 2007 Financial Results

03/11/2021 - Opexa Therapeutics Announces Completion of Mid Study Descriptive Analysis on Phase IIb Trial of ...

02/19/2008 - Opexa Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Series E ...

02/13/2008 - Opexa Therapeutics Announces the Pricing of Public Offering of Shares of Common Stock and Series E ...